Advertisement

Immunosenescence and Respiratory Infections Among Nursing Home Residents

  • Mark Loeb
Living reference work entry

Abstract

Residents of nursing homes are at high risk of infectious complications due to respiratory infection. The nursing home setting places residents at high risk given the frequent contact among residents and by staff along with the possibility for continuous introduction of respiratory viruses from the community. Nursing home residents are among the most frail members of society. They have multiple comorbidities that can increase their risk of infection. Immunosenescence plays an important role in not only rendering these seniors susceptible in infection, particularly viral respiratory infection, but also interferes with protection. That is, the ability to mount a robust immune response to influenza and pneumococcal vaccine increase the risk. There have been a number of T-cell deficits described in this population. CD4+ T cells, in particular T-regs and CMV-reactive CD4+ T-cells, have been shown to be predictive of respiratory viral infection in this population. Although evidence exists that T-cell subsets may correlate better with response to vaccine and protection, antibody responses to influenza vaccine remains an important correlate in this population. Large-scale epidemiologic studies are needed to establish better correlation between biomarkers for protection and respiratory and other pathogens that circulate in nursing homes.

Keywords

Nursing homes Respiratory infection Influenza Innate immunity Clinical studies 

References

  1. Bowles SK, Lee W, Simor AE, Vearncombe M, Loeb M, Tamblyn S, Fearon M, Li Y, McGeer A, Oseltamivir Compassionate Use Program Group (2002) Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999-2000. J Am Geriatr Soc 50(4):608–616CrossRefPubMedGoogle Scholar
  2. Centers for Disease Control and Prevention (CDC) (2013) Outbreaks of human metapneumovirus in two skilled nursing facilities -West Virginia and Idaho, 2011-2012. MMWR Morb Mortal Wkly Rep 62(46):909–913Google Scholar
  3. Collerton J, Martin-Ruiz C, Davies K, Hilkens C, Isaacs J, Kolenda C, Parker C, Dunn M, Catt M, Jagger C, von Zglinicki T, Kirkwood T (2012) Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ study. Mech Ageing Dev 14:456–466CrossRefGoogle Scholar
  4. Cossarizza A, Ortolani C, Paganelli R, Barbieri D, Monti D, Sansoni P, Fagiolo U, Castellani G, Bersani F, Londei M, Franceschi C (1996) CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to centenarians: implications for cell memory. Mech Ageing Dev 14:173–195.  https://doi.org/10.1016/0047-6374(95)01691-0CrossRefGoogle Scholar
  5. Derhovanessian E, Theeten H, Hahnel K, Van Damme P, Cools N et al (2013) Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination. Vaccine 31:685–690CrossRefPubMedGoogle Scholar
  6. den Elzen W, Vossen A, Cools H, Westendorp R, Kroes A et al (2011) Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities. Vaccine 29:4869–4874CrossRefGoogle Scholar
  7. Eurich DT, Marrie TJ, Johnstone J, Majumdar SR (2008) Mortality reduction with influenza vaccine in patients with pneumonia outside “flu” season: pleiotropic benefits or residual confounding? Am J Respir Crit Care Med 178(5):527–533CrossRefPubMedGoogle Scholar
  8. Fahey J, Schnelle J, Boscardin J, Thomas J, Gorre ME, Aziz N, Sadeghi H, Nishanian P (2000) Distinct categories of immunologic changes in frail elderly. Mech Ageing Dev 14:1–20CrossRefGoogle Scholar
  9. Fulop T, Larbi A, Wikby A, Mocchegiani E, Hirokawa K, Pawelec G (2005) Dysregulation of T-cell function in the elderly : scientific basis and clinical implications. Drugs Aging 22(7):589–603CrossRefPubMedGoogle Scholar
  10. Gorišek Miksić N, Uršič T, Simonović Z, Lusa L, Lobnik Rojko P, Petrovec M, Strle F (2015) Oseltamivir prophylaxis in controlling influenza outbreak in nursing homes: a comparison between three different approaches. Infection 43(1):73–81CrossRefPubMedGoogle Scholar
  11. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS (2006a) Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 35(2):337–344CrossRefPubMedGoogle Scholar
  12. Jackson LA, Nelson JC, Benson P, Neuzil KM, Reid RJ, Psaty BM, Heckbert SR, Larson EB, Weiss NS (2006b) Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 35(2):345–352CrossRefPubMedGoogle Scholar
  13. Jackson ML, Yu O, Nelson JC, Naleway A, Belongia EA, Baxter R, Narwaney K, Jacobsen SJ, Shay DK, Jackson LA (2013) Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic. Am J Epidemiol 178(8):1327–1336CrossRefPubMedGoogle Scholar
  14. Johnstone J, Millar J, Lelic A et al (2014a) Immunosenescence in the nursing home elderly. BMC Geriatr 14:50.  https://doi.org/10.1186/1471-2318-14-50CrossRefPubMedPubMedCentralGoogle Scholar
  15. Johnstone J, Parsons R, Botelho F, Millar J, McNeil S, Fulop T, McElhaney J, Andrew MK, Walter SD, Devereaux PJ, Malekesmaeili M, Brinkman RR, Mahony J, Bramson J, Loeb M (2014b) Immune biomarkers predictive of respiratory viral infection in elderly nursing home residents. PLoS One 9(9):e108481CrossRefPubMedPubMedCentralGoogle Scholar
  16. Koch S, Larbi A, Ozcelik D, Solana R, Gouttefangeas C et al (2007) Cytomegalovirus: a driving force in human T-cell immunosenescence. Ann N Y Acad Sci 1114:23–25CrossRefPubMedGoogle Scholar
  17. Kupronis BA, Richards CL, Whitney CG, Active Bacterial Core Surveillance Team (2003) Invasive pneumococcal disease in older adults residing in long-term care facilities and in the community. J Am Geriatr Soc 51(11):1520–1525CrossRefPubMedGoogle Scholar
  18. Loeb M, McGeer A, McArthur M, Peeling RW, Petric M, Simor AE (2000) Surveillance for outbreaks of respiratory tract infections in nursing homes. CMAJ 162(8):1133–1137PubMedPubMedCentralGoogle Scholar
  19. Masse S, Minodier L, Heuze G, Blanchon T, Capai L, Falchi A (2016) Influenza-like illness outbreaks in nursing homes in Corsica, France, 2014-2015: epidemiological and molecular characterization. Springerplus 5(1):1338CrossRefPubMedPubMedCentralGoogle Scholar
  20. McKimm-Breschkin JL (2005) Management of influenza virus infections with neuraminidase inhibitors: detection, incidence, and implications of drug resistance. Treat Respir Med 4(2):107–116CrossRefPubMedGoogle Scholar
  21. Meijer A, Overduin P, Hommel D, van Rijnsoever-Greven Y, Haenen A, Veldman-Ariesen MJ (2013) Outbreak of respiratory syncytial virus infections in a nursing home and possible sources of introduction: the Netherlands, winter 2012/2013. J Am Geriatr Soc 61(12):2230–2231CrossRefPubMedGoogle Scholar
  22. Meydani SN, Leka LS, Fine BC, Dallal GE, Keusch GT, Singh MF, Hamer DH (2004) Vitamin E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial. JAMA 292(7):828–836CrossRefPubMedPubMedCentralGoogle Scholar
  23. Mitchell R, Huynh V, Pak J, Thompson S, Noseworthy AL (2006) Influenza outbreak in an Ontario long-term care home – January 2005. Can Commun Dis Rep 32(21):257–262PubMedGoogle Scholar
  24. Monto AS, Rotthoff J, Teich E, Herlocher ML, Truscon R, Yen HL, Elias S, Ohmit SE (2004) Detection and control of influenza outbreaks in well-vaccinated nursing home populations. Clin Infect Dis 39(4):459–464CrossRefPubMedGoogle Scholar
  25. Pawelec G, Derhovanessian E, Larbi A, Strindhall J, Wikby A et al (2009) Cytomegalovirus and human immunosenescence. Rev Med Virol 19:47–56CrossRefPubMedGoogle Scholar
  26. Rivetti D, Jefferson T, Thomas R, Rudin M, Rivetti A, Di Pietrantonj C, Demicheli V (2006) Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 3:CD004876Google Scholar
  27. Rockwood K, Abeysundera M, Mitnitski A (2007) How should we grade frailty in nursing home patients? J Am Med Dir Assoc 14:595–603CrossRefGoogle Scholar
  28. Saule P, Trauet J, Dutriez V, Lekeux V, Dessaint JP, Labalette M (2006) Accumulation of memory T cells from childhood to old age: central and effector memory cells in CD4(+) versus effector memory and terminally differentiated memory cells in CD8(+) compartment. Mech Ageing Dev 127(3):274–281CrossRefPubMedGoogle Scholar
  29. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA (2007) Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 7(10):658–666CrossRefPubMedGoogle Scholar
  30. Strausbaugh LJ, Sukumar SR, Joseph CL (2003) Infectious disease outbreaks in nursing homes: an unappreciated hazard for frail elderly persons. Clin Infect Dis 36(7):870–876CrossRefPubMedGoogle Scholar
  31. Todd Faulks J, Drinka PJ, Shult P (2000) A serious outbreak of parainfluenza type 3 on a nursing unit. J Am Geriatr Soc 48(10):1216–1218CrossRefPubMedGoogle Scholar
  32. Trzonkowski P, Mysliwska J, Szmit E, Wieckiewicz J, Lukaszuk K et al (2003) Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination – an impact of immunosenescence. Vaccine 21:3826–3836CrossRefPubMedGoogle Scholar
  33. Utsumi M, Makimoto K, Quroshi N, Ashida N (2010) Types of infectious outbreaks and their impact in elderly care facilities: a review of the literature. Age Ageing 39(3):299–305CrossRefPubMedGoogle Scholar
  34. Wack A, Cossarizza A, Heltai S, Barbieri D, D’Addato S, Fransceschi C, Dellabona P, Casorati G (1998) Age-related modifications of the human alphabeta T cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsets. Int Immunol 10(9):1281–1288CrossRefPubMedGoogle Scholar
  35. Wang L, Xie Y, Zhu L, Chang T, Mao Y et al (2010) An association between immunosenescence and CD4+CD25+ regulatory T-cells: a systematic review. Biomed Environ Sci 23:327–332CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Pathology and Molecular MedicineMcMaster UniversityHamiltonCanada
  2. 2.Department of Clinical Epidemiology and BiostatisticsMcMaster UniversityHamiltonCanada
  3. 3.Institute for Infectious Diseases ResearchMcMaster UniversityHamiltonCanada

Personalised recommendations